S'abonner

Usefulness of the CHADS2 Score for Determining Risk of Seizure in Patients With Atrial Fibrillation - 22/10/16

Doi : 10.1016/j.amjcard.2016.07.063 
Chien-Yi Hsu, MD a, b, c, d, Tz-Heng Chen, MD a, e, Yu-Wen Su, MD a, f, Chun-Chin Chang, MD a, b, g, Mu-Hong Chen, MD h, Hsin-Bang Leu, MD, PhD a, b, e, i, Po-Hsun Huang, MD, PhD a, b, e, , Jaw-Wen Chen, MD a, e, j, k, Shing-Jong Lin, MD, PhD a, b, c, d, e, j
a Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan 
b Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan 
k Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan 
c Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan 
d Division of Cardiology and Cardiovascular Research Center, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 
e Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 
f Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan 
g Department of Medicine, Taipei Veterans General Hospital Taoyuan Branch, Taoyuan, Taiwan 
h Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan 
i Healthcare and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan 
j Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan 

Corresponding author: Tel: +886-2-2875-7434; fax: +886-2-2876-3336.

Abstract

Atrial fibrillation (AF) secondary to seizure has been described in case reports, but the association between AF and risk of seizure has never been evaluated in longitudinal studies. The objectives of this study were to investigate the role of AF on the risk of development of seizure and the usefulness of CHADS2 score for predicting the risk of seizure. Our analyses were conducted using information from a random sample of 1 million subjects enrolled in Taiwan National Health Insurance Research Database. A total of 11,552 subjects aged ≥18 years, comprising 5,776 subjects diagnosed with AF during the study period and 5,776 age and sex-matched subjects without AF were enrolled in our study. During the mean follow-up of 6.7 ± 3.3 years, seizure events occurred in 235 patients. In comparison, the AF group had a higher incidence rate of seizure occurrence (4.17 vs 1.90 per 1,000 person-years). Cox proportional hazard regression model analysis showed that development of AF was independently associated with a higher risk of developing future seizure (adjusted HR 2.30; 95% confidence interval 1.73 to 3.05). In multivariate Cox regression analysis adjusted for potentially confounding variables, a higher CHADS2 score was associated with a higher risk of seizure in a dose-dependent manner. AF may cause an ischemic stroke that subsequently leads to seizure, and present study further demonstrates that AF patients are associated with higher rate of subsequent seizure, even after adjusting for stroke. The CHADS2 score was found to be a useful scheme for predicting the risk of seizure occurrence.

Le texte complet de cet article est disponible en PDF.

Plan


 Drs Hsu and Chen contributed equally to this work.
 Contributions: Research idea and study design: Drs Hsu and Chen; data acquisition: Chang, Su, and Chen; data analysis/interpretation: Drs Hsu, Chen, and Huang; statistical analysis: Drs Hsu, Chen, and Leu; supervision or mentorship: Drs Huang, Chen, and Lin. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved. Dr. Huang takes responsibility that this study has been reported honestly, accurately, and transparently; that no important aspects of the study have been omitted and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
 This study was supported, in part, by the following research grants: Novel Bioengineering and Technological Approaches to Solve Two Major Health Problems in Taiwan sponsored by the Taiwan Ministry of Science and Technology Academic Excellence Program (Taipei, Taiwan) under grant number: MOST 105-2633-B-009-003; V103A-009 from Taipei Veterans General Hospital, Taipei, Taiwan; a grant from the Ministry of Health and Welfare, Taiwan (MOHW 104-TDU-B-211-113-003). Funding agencies had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.
 See page 1344 for disclosure information.


© 2016  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 118 - N° 9

P. 1340-1344 - novembre 2016 Retour au numéro
Article précédent Article précédent
  • Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry
  • Fei Song, Mengyue Yu, Jingang Yang, Haiyan Xu, Yanyan Zhao, Wei Li, Dewei Wu, Zhifang Wang, Qingsheng Wang, Xiaojin Gao, Yang Wang, Rui Fu, Yi Sun, Runlin Gao, Yuejin Yang, China Acute Myocardial Infarction (CAMI) Registry study group
| Article suivant Article suivant
  • Usefulness of the Atrial Emptying Fraction to Predict Maintenance of Sinus Rhythm After Direct Current Cardioversion for Atrial Fibrillation
  • Christina L. Luong, Darby J.S. Thompson, Kenneth G. Gin, John Jue, Parvathy Nair, Pui-Kee Lee, Michael Y. Tsang, Marion E. Barnes, Pamela Colley, Teresa S.M. Tsang

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.